Voxelotor

A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease

Voxelotor CYP and Transporter Cocktail Interaction Study

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia

Voxelotor for Improving Oxygen Saturation in Adults

Assessing Physical Function in Sickle Cell Patients Taking Voxelotor

Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Open-Label Extension of Voxelotor

Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Voxelotor (GBT440) in Pediatric Participants with Sickle Cell Disease (HOPE Kids 2)

Resolution of Sickle Cell Leg Ulcers with Voxelotor (RESOLVE)

Open-Label Extension of Voxelotor

An Open Label Extension Study of Voxelotor (GBT440) Administered Orally to Participants with Sickle Cell Disease Who Have Participated in Voxelotor Clinical Trials

Actigraphy Improvement With Voxelotor (ActIVe) Study

Voxelotor Sickle Cell Exercise Study

Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options